Literature DB >> 28965283

Identification of antigens from nosocomial Acinetobacter baumannii clinical isolates in sera from ICU staff and infected patients using the antigenome technique.

Tina Nafarieh1, Mojgan Bandehpour2, Ali Hashemi3, Sodabeh Taheri3, Vahid Yardel4, Hamidreza Jamaati5, Seyed Mahdi Moosavi6, Nariman Mosaffa7.   

Abstract

Nosocomial infections with a bacterial origin are considered one of the most dangerous threats to global health. Among the causes of these infections, Acinetobacter baumannii is playing a significant role, and the present study aimed‏ to determine the immunogenic proteins of this bacteria. Clinical isolates of A. baumannii were obtained from positive sputum cultures of intensive care unit (ICU) patients confirmed by Polymerase chain reaction (PCR) of the OXA-51 gene, and sera was obtained from 20 colonized patients. In addition, 20 and 30 serum samples were collected from ICU nurses and healthy controls, respectively. All the samples were screened in the presence of antibodies against A. baumannii by enzyme-linked immunosorbent assay (ELISA). IgG purified from the serum samples by affinity chromatography was used to isolate the bacteria by the Magnetic-activated cell sorting (MACS) procedure. After the bacteria were cultured, the identified antigen proteins were studied by western blotting and Mass spectrometry (MS). The MS results were analyzed with MASCOT software and revealed a 35 KD protein, which corresponds to outer membrane protein A (OmpA) of A. baumannii, a 25 KD band, which is a carbapenem-associated resistance protein precursor, and a 60 KD protein band, identified as a stress-induced bacterial acidophilic repeat motif protein. According to the properties of immunogen antigens and bio informatics tools, the outer membrane proteins (OMPs) can be used as a vaccine candidate in animal models.

Entities:  

Keywords:  Acinetobacter baumannii; Antigenome technology; ICU; Nosocomial infection; Outer membrane protein; Vaccination

Mesh:

Substances:

Year:  2017        PMID: 28965283     DOI: 10.1007/s11274-017-2355-x

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  30 in total

1.  Active surveillance for multidrug-resistant Gram-negative bacteria in the intensive care unit.

Authors:  Iain J Abbott; Adam W J Jenney; Denis W Spelman; David V Pilcher; Hanna E Sidjabat; Leisha J Richardson; David L Paterson; Anton Y Peleg
Journal:  Pathology       Date:  2015-10       Impact factor: 5.306

2.  Antigenome technology: a novel approach for the selection of bacterial vaccine candidate antigens.

Authors:  Andreas Meinke; Tamás Henics; Markus Hanner; Duc Bui Minh; Eszter Nagy
Journal:  Vaccine       Date:  2005-03-18       Impact factor: 3.641

3.  Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii.

Authors:  Michael J McConnell; Carlos Rumbo; Germán Bou; Jerónimo Pachón
Journal:  Vaccine       Date:  2011-06-14       Impact factor: 3.641

4.  Outbreak of multidrug-resistant Acinetobacter baumannii in an intensive care unit.

Authors:  Marco Dettori; Andrea Piana; Maria Grazia Deriu; Paola Lo Curto; Andrea Cossu; Rosario Musumeci; Clementina Cocuzza; Vito Astone; Maria Antonietta Contu; Giovanni Sotgiu
Journal:  New Microbiol       Date:  2014-04-01       Impact factor: 2.479

5.  Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology.

Authors:  Ming-Hsien Chiang; Wang-Chou Sung; Shu-Pei Lien; Ying-Zih Chen; Annie Fei-yun Lo; Jui-Hsin Huang; Shu-Chen Kuo; Pele Chong
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 6.  Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond.

Authors:  Brent S Weber; Christian M Harding; Mario F Feldman
Journal:  J Bacteriol       Date:  2015-12-28       Impact factor: 3.490

7.  Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes.

Authors:  Lin Lin; Brandon Tan; Paul Pantapalangkoor; Tiffany Ho; Andrea M Hujer; Magdalena A Taracila; Robert A Bonomo; Brad Spellberg
Journal:  Vaccine       Date:  2012-11-12       Impact factor: 3.641

Review 8.  First steps towards a vaccine against Acinetobacter baumannii.

Authors:  Meritxell Garcia-Quintanilla; Marina R Pulido; Michael J McConnell
Journal:  Curr Pharm Biotechnol       Date:  2013       Impact factor: 2.837

9.  Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumannii.

Authors:  Danilo G Moriel; Scott A Beatson; Daniël J Wurpel; Jeffrey Lipman; Graeme R Nimmo; David L Paterson; Mark A Schembri
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

10.  Regulation Systems of Bacteria such as Escherichia coli in Response to Nutrient Limitation and Environmental Stresses.

Authors:  Kazuyuki Shimizu
Journal:  Metabolites       Date:  2013-12-30
View more
  3 in total

1.  Microevolution in the major outer membrane protein OmpA of Acinetobacter baumannii.

Authors:  Alejandro M Viale; Benjamin A Evans
Journal:  Microb Genom       Date:  2020-06-04

Review 2.  Advanced strategies for development of vaccines against human bacterial pathogens.

Authors:  Abhinay Sharma; Pooja Sanduja; Aparna Anand; Pooja Mahajan; Carlos A Guzman; Puja Yadav; Amit Awasthi; Emanuel Hanski; Meenakshi Dua; Atul Kumar Johri
Journal:  World J Microbiol Biotechnol       Date:  2021-03-22       Impact factor: 3.312

3.  Cloning, expression, purification and functional analysis of a specific multi-epitope protein from multi drug resistance Acinetobacter baumannii.

Authors:  Zahra Davoudi; Amirhossein Taromchi; Bahram Kazemi; Mojgan Bandehpour; Nariman Mosaffa
Journal:  Iran J Microbiol       Date:  2021-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.